ZA200406548B - Process for the preparation of morpholine derivatives and intermediates therefor. - Google Patents

Process for the preparation of morpholine derivatives and intermediates therefor. Download PDF

Info

Publication number
ZA200406548B
ZA200406548B ZA200406548A ZA200406548A ZA200406548B ZA 200406548 B ZA200406548 B ZA 200406548B ZA 200406548 A ZA200406548 A ZA 200406548A ZA 200406548 A ZA200406548 A ZA 200406548A ZA 200406548 B ZA200406548 B ZA 200406548B
Authority
ZA
South Africa
Prior art keywords
formula
alkyl
compound
aryl
heteroaryl
Prior art date
Application number
ZA200406548A
Other languages
English (en)
Inventor
Martin Alistair Hayes
Mark Wilkinson Andrew Jo Mills
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200406548B publication Critical patent/ZA200406548B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200406548A 2002-03-28 2004-08-17 Process for the preparation of morpholine derivatives and intermediates therefor. ZA200406548B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207450.8A GB0207450D0 (en) 2002-03-28 2002-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200406548B true ZA200406548B (en) 2005-09-19

Family

ID=9933999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200406548A ZA200406548B (en) 2002-03-28 2004-08-17 Process for the preparation of morpholine derivatives and intermediates therefor.

Country Status (20)

Country Link
EP (1) EP1487809B1 (de)
JP (1) JP2005532281A (de)
KR (1) KR20050008664A (de)
CN (1) CN1642928A (de)
AR (1) AR039178A1 (de)
AT (1) ATE383349T1 (de)
AU (1) AU2003226760A1 (de)
BR (1) BR0308720A (de)
CA (1) CA2479819A1 (de)
DE (1) DE60318559T2 (de)
ES (1) ES2298539T3 (de)
GB (1) GB0207450D0 (de)
IS (1) IS7401A (de)
MX (1) MXPA04009457A (de)
NO (1) NO20044036L (de)
PL (1) PL373972A1 (de)
RU (1) RU2004125289A (de)
TW (1) TW200401772A (de)
WO (1) WO2003082835A1 (de)
ZA (1) ZA200406548B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
US10702521B2 (en) 2014-08-22 2020-07-07 Glaxosmithkline Intellectual Property Development Limited Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
WO2019168874A1 (en) 2018-02-27 2019-09-06 The Research Foundation For The State University Of New York Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2447732A1 (de) * 1974-10-07 1976-04-08 Wuelfing J A Fa Neue morpholinverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
KR20010014105A (ko) * 1997-06-23 2001-02-26 가마쿠라 아키오 헬리코박터 감염에 기인한 질환의 예방 또는 치료제
BR0114321A (pt) * 2000-09-29 2003-07-01 Glaxo Group Ltd Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto

Also Published As

Publication number Publication date
RU2004125289A (ru) 2005-06-27
DE60318559D1 (de) 2008-02-21
EP1487809B1 (de) 2008-01-09
BR0308720A (pt) 2005-01-04
PL373972A1 (en) 2005-09-19
CA2479819A1 (en) 2003-10-09
JP2005532281A (ja) 2005-10-27
DE60318559T2 (de) 2009-01-08
EP1487809A1 (de) 2004-12-22
IS7401A (is) 2004-08-12
GB0207450D0 (en) 2002-05-08
TW200401772A (en) 2004-02-01
NO20044036L (no) 2004-09-29
AU2003226760A1 (en) 2003-10-13
ES2298539T3 (es) 2008-05-16
ATE383349T1 (de) 2008-01-15
WO2003082835A1 (en) 2003-10-09
MXPA04009457A (es) 2005-01-25
KR20050008664A (ko) 2005-01-21
CN1642928A (zh) 2005-07-20
AR039178A1 (es) 2005-02-09

Similar Documents

Publication Publication Date Title
JP6777398B2 (ja) 薬剤を調製するための方法と中間体
CA2530159C (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
FR2921657A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique
JP2020524158A (ja) Ssao阻害剤
MXPA04002653A (es) Metodo para preparar compuestos de pirimidinona y sales farmaceuticamente aceptables del mismo.
CN118047774A (zh) 一种制备非奈利酮及其中间体的方法
US7915427B2 (en) Process for producing aminoacetyl pyrrolidine carbonitrile derivative and intermediate for production thereof
ZA200406548B (en) Process for the preparation of morpholine derivatives and intermediates therefor.
Huang et al. A facile approach to trans-4, 5-pyrrolidine lactam and application in the synthesis of nemonapride and streptopyrrolidine
JP2022528690A (ja) (3r,4r)-1-ベンジル-n,4-ジメチルピペリジン-3-アミンまたはその塩の製造方法、およびそれを使用したトファシチニブの製造方法
Nagamine et al. A New Chiral Synthesis of a Bicyclic Enedlone Containing a Seven-Membered Ring Mediated by a Combination of Chiral Amine and Bronsted Acid
AU2006277710A1 (en) Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles
FR2943675A1 (fr) Composes anticancereux, leur preparation et leur application en therapeutique
Chai et al. Urazole synthesis. Part 2: facilitating N4 substitution
Chen et al. Synthesis, Characterization and Suppression of Impurities during Optimization of Dabigatran Etexilate
EP2058300A1 (de) Bernsteinsäurediesterderivat, verfahren zu dessen herstellung und verwendung des derivats bei der herstellung einer pharmazeutischen zubereitung
Xu et al. Impact of atropisomerism on a non-steroidal glucocorticoid receptor agonist
OA13178A (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors.
Zhang et al. A facile and efficient synthesis of d3‐labelled Reyataz™
FR2943670A1 (fr) Derives anticancereux,leur preparation et leur application en therapeutique
KR20220011669A (ko) Btk 억제제 제조를 위한 방법 및 중간체
WO2010092286A1 (fr) Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique